Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFernandes de Rafael, Diana
dc.contributor.authorDa Silva Andrade, Fernanda Raquel
dc.contributor.authorMartínez Trucharte, Francesc
dc.contributor.authorBasas Satorras, Jana
dc.contributor.authorSeras Franzoso, Joaquin
dc.contributor.authorPerez Burgos, Marc
dc.contributor.authorBlanco Grau, Albert
dc.contributor.authorLópez Fernandez, Alba
dc.contributor.authorVélez Villa, Roberto
dc.contributor.authorAbasolo Olaortua, Ibane
dc.contributor.authorAguirre Canyadell, Màrius
dc.contributor.authorGavaldà Santapau, Joan
dc.contributor.authorSchwartz Navarro, Simon
dc.contributor.authorPalau Gauthier, Marta
dc.contributor.authorGomis Rodriguez, Javier
dc.date.accessioned2019-04-09T11:14:07Z
dc.date.available2019-04-09T11:14:07Z
dc.date.issued2019-03-06
dc.identifier.citationRafael D, Andrade F, Martinez-Trucharte F, Basas J, Seras-Franzoso J, Palau M, et al. Sterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications. Nanomaterials. 2019; 9(3):e380.
dc.identifier.issn2079-4991
dc.identifier.urihttps://hdl.handle.net/11351/4032
dc.descriptionAnti-bacterial agents; Post-operative infections; Silver nanoparticles
dc.description.abstractHydrogels (HG) have recognized benefits as drug delivery platforms for biomedical applications. Their high sensitivity to sterilization processes is however one of the greatest challenges regarding their clinical translation. Concerning infection diseases, prevention of post-operatory related infections is crucial to ensure appropriate patient recovery and good clinical outcomes. Silver nanoparticles (AgNPs) have shown good antimicrobial properties but sustained release at the right place is required. Thus, we produced and characterized thermo-sensitive HG based on Pluronic® F127 loaded with AgNPs (HG-AgNPs) and their integrity and functionality after sterilization by dry-heat and autoclave methods were carefully assessed. The quality attributes of HG-AgNPs were seriously affected by dry-heat methods but not by autoclaving methods, which allowed to ensure the required sterility. Also, direct sterilization of the final HG-AgNPs product proved more effective than of the raw material, allowing simpler production procedures in non-sterile conditions. The mechanical properties were assessed in post mortem rat models and the HG-AgNPs were tested for its antimicrobial properties in vitro using extremely drug-resistant (XDR) clinical strains. The produced HG-AgNPs prove to be versatile, easy produced and cost-effective products, with activity against XDR strains and an adequate gelation time and spreadability features and optimal for in situ biomedical applications.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesNanomaterials;9(3)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectEsterilització
dc.subjectInfecció - Prevenció
dc.subjectCol·loides
dc.subject.meshSterilization
dc.subject.mesh/methods
dc.subject.meshHydrogels
dc.subject.meshInfection
dc.subject.mesh/prevention & control
dc.titleSterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/nano9030380
dc.subject.decsesterilización
dc.subject.decs/métodos
dc.subject.decshidrogeles
dc.subject.decsinfección
dc.subject.decs/prevención & control
dc.relation.publishversionhttps://www.mdpi.com/2079-4991/9/3/380
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Rafael D] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Networking Research Centre for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain. [Andrade F] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. INEB-Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Porto, Portugal. [Martinez-Trucharte F] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Basas J] Laboratori de Resistencia Antimicrobiana, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain. [Seras-Franzoso J] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Palau M] Laboratori de Resistencia Antimicrobiana, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain. [Gomis X] Laboratori de Resistència Antimicrobiana, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Pérez-Burgos M] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Blanco A] Servei de Cirurgia Ortopèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Grup en Enginyeria tissular musculoesquelètica, Vall d’Hebron Institut de Recerca, Barcelona, Spain. [López-Fernández A] Grup en Enginyeria tissular musculoesquelètica, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Vélez R] Servei de Cirurgia Ortopèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Grup en Enginyeria tissular musculoesquelètica, Vall d’Hebron Institut de Recerca, Barcelona, Spain. [Abasolo I] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Networking Research Centre for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain. [Aguirre M] Servei de Cirugia Ortopedica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Gavaldà J] Laboratori de Resistencia Antimicrobiana, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain. [Schwartz S Jr] Grup Drug Delivery & Targeting (DDT), Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Networking Research Centre for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.
dc.identifier.pmid30845683
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record